CURRENT CONFERENCE
Joint CVG/Therapeutic Products Directorate (TPD)
2008  CONFERENCE AND EXHIBITIONS

"From Block Buster to Boutique Products - 
Copping with Changes"

October 9-10 2007 (Toronto, Ontario, Canada)
Double Tree International Plaza Hotel, 655 Dixon Road, Toronto
Tel: 416-244-1711,

 Program and Presentations in PDF

 
Introduction and Start of Program David Mayers 8:40AM - 8:45AM
Opening Remarks Herman Lam, Ph.D. 8:45AM - 8:50PM
Key Note Address:
Blockbuster to Boutique Products - A regulatory perspective

Dr. Alan Viau
Acting Director, BPS, Health Canada

8:50AM - 9:35AM
Regulatory Modernization and the Quality Endeavor

Dr. Chris Watts
FDA

9:35AM - 10:20AM
Morning Break   10:20AM - 10:50AM
Heavy metal in pharmaceutical ingredients Dr. Kahkashan Zaidi
USP
10:50AM - 11:25AM

Regulatory challenges in product characterization

Dr. Denis Girard
Senior Scientific Advisor, BPS
11:25AM - 12:00PM
Lunch Break 12:00PM - 2:00PM
Continues coating process O'Hara Technologies Inc.
Mr. Jim Matjeram
2:00PM - 2:35PM
The Impact of Automation on Routine Performance Verification Testing Dr. Michael Allen
ThermoFisher
2:35PM - 3:10PM
Break 3:10PM - 3:40PM
From Tox to Phase 1:  What Do You Need?  Dr. Chung Chow Chan
Technical Director,
Azopharma
3:40PM - 4:15PM

Personalized medicine: opportunity or threat – an overview of technology trends and biotech industry activities.

Dr. Robert Foldes
Executive Director
YORKBiotech Inc.
4:15PM - 4:50PM
Wrap Up for the Day and Door Prizes Elaine Vandenberg Ph.D. 4:50PM - 5:15PM
 
October 5, 2007: Discussion Group Sessions
Breakfast   8:30AM - 9:00AM
Round Table Parallel Discussion Sessions   9:00AM - 12:15PM
 

Round Table Parallel Discussion Sessions (9:00AM-12:15PM)

      Session 1: Analytical Sciences        
Chair: David Mayers, Purdue Pharma 

TeraHertz Spectroscopy Mr. Mark Kemper
(Picometrix LLC)
Calibration of NIR Spectrophotometers Dr. Herman Lam
Wild Crane Horizon
Break 
Sub 2um Particles for Reverse Phase Chromatography: Benefits, Concerns and a Guide to Column Selection Dr. Christine Hand
Waters
Mechanical calibration for dissolution apparatus Ms. Judy Clucas 
Varians

Session 2: Pharmaceutical Quality and Regulatory Round Table Discussion
Chair: Elaine Vandenberg, Ph.D., GlaxoSmithKline Canada Inc.

 Case studies in product characterization

Dr. Phillip Hurst Senior Reviewer BPS, TPD
From Phase 1to Phase 2:  What Do You Need?  Dr. Chung Chow Chan
Technical Director,
Azopharma
Break  
Round Table discussion Dr. Chris Watts
FDA
Round Table discussion Dr. Kahkashan Zaidi
USP
Program Committee
Krishnan Tirunellai, Ph. D., TPD
David Mayers, Purdue Pharma (Chair)
William Ng, Purdue Pharma
Tony Cheung, Purdue Pharma
Herman Lam, Ph.D., Wild Crane Horizon.
Elaine Vandenberg, Ph.D., GlaxoSmithKline Canada Inc.
CVG Executive Board
Herman Lam, Ph.D.
Chung Chow Chan, Ph.D.
YC Lee, Ph.D.
Xue-Ming Zhang, Ph.D.
Katherine Yang, Ph.D.
David Mayers, 
Gabriel Lam
Wei Garofolo
William Ng
Tony Cheung
Yu-Hong Tse, Ph.D.
Fabio Garofolo, Ph.D.

Copyright © CVG 2005. All Rights Reserved
Website designed by TereDesign